Cristóbal Morales
Cristóbal Morales is a member of the Spanish Society of Obesity and has commented on the broader systemic issues facing individuals with obesity in Spain, particularly how socioeconomic factors can severely impact their health outcomes and access to treatment.
Not in the pool (under ¢1).
Recent news mentions
Specialist Cristóbal Morales alerts that the powdered format of Mounjaro may not meet safety requirements.
Venda il·legal d'un fàrmac per aprimar des d'Andorra cap a Espanya
Andorra· 2025-12-02
Cristóbal Morales is an endocrinologist who has participated in numerous studies on weight loss medications and emphasizes the complexity of obesity as a disease.
La OMS reconoce los fármacos adelgazantes como esenciales para la humanidad: “Deben ser accesibles universalmente” | Salud y bienestar
Spain· 2025-12-01
Cristóbal Morales is an endocrinologist who discusses the effectiveness of Orforglipron in weight loss.
Pastila revoluționară care ar putea înlocui Ozempic și Mounjaro: slăbești până la 20 kg în câteva luni fără injecții
Romania· 2025-09-23Cristóbal Morales explains that there are many types of obesity and emphasizes the complexity of the condition.
El problema del “si yo puedo, tú también”: ¿es lícito decepcionarse cuando un famoso decide adelgazar? | ICONSpain· 2025-07-11
Cristóbal Morales, an endocrinologist at the Virgen Macarena University Hospital in Seville, states that these drugs are very safe and have been used for 20 years in diabetes.
Pancreatitis, Ozempic y titulares exagerados: una alerta en el Reino Unido despierta dudas sobre el abuso del fármaco | Salud y bienestarSpain· 2025-07-03
Cristóbal Morales is an endocrinologist at the Virgen Macarena University Hospital in Seville.
Llegan los nuevos fármacos antiobesidad que ya superan al Ozempic | Salud y bienestarSpain· 2025-03-07
Cristóbal Morales emphasizes the need for social services to assist patients with obesity.
Cómo acabó Pilar atrapada con más de 200 kilos en un sexto piso | EspañaSpain· 2025-02-10
